Exhibit 10.11


 


THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS
ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.


 


THE PURCHASE OF THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.


 


SUBSCRIPTION AGREEMENT


 


This Subscription Agreement (this “Agreement”)
is entered into as of July 8, 2021 between Hennessy Capital Investment Corp. VI, a Delaware corporation (the “Company”),
Hennessy Capital Partners VI LLC, a Delaware limited liability company (the “Sponsor”) and D. E. Shaw Valence Portfolios,
L.L.C. (“Valence Portfolios”), and solely with respect to the purchase of the Founder Shares, its wholly-owned subsidiary
D. E. Shaw Valence Investments (Cayman) Limited (“Valence Investments”, and together with Valence Portfolios, the “Purchaser”).


 


RECITALS


 


WHEREAS, the Company was incorporated for the purpose
of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination
with one or more businesses (a “Business Combination”);


 


WHEREAS, the Company has filed with the U.S. Securities
and Exchange Commission (the “SEC”) a registration statement on Form S-1 (the “Registration Statement”)
for its initial public offering (“IPO”) of units (the “Public Units”), at a price of $10.00 per
Public Unit, where each Public Unit is currently contemplated to be comprised of one share of the Company’s Class A common stock,
par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common Stock included in the Public
Units, the “Public Shares”), and a portion of one redeemable warrant, where each whole warrant is initially exercisable
to purchase one share of Class A Common Stock at an exercise price of $11.50 per share, subject to adjustment (the “Warrants”,
and the Warrants included in the Public Units, the “Public Warrants”);


 


WHEREAS, proceeds from the IPO and the sale of
the Private Placement Warrants (as defined below) in an aggregate amount equal to the aggregate gross proceeds from the IPO will be deposited
into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”), as described in the
Registration Statement;


 


WHEREAS, following the closing of the IPO (the
“IPO Closing”), the Company will seek to identify and consummate a Business Combination;


 


WHEREAS, in connection with the IPO, the Sponsor
and the Purchaser will purchase, in a private placement that will close simultaneously with the IPO Closing, Warrants which are identical
to the Public Warrants except that they will be non-redeemable (in certain circumstances) and exercisable on a cashless basis so long
as they are held by the Sponsor, the Purchaser or their respective permitted transferees (the “Private Placement Warrants”),
for a purchase price of $1.50 per Private Placement Warrant;


  


WHEREAS, the parties wish to enter into this Agreement,
pursuant to which the Purchaser shall subscribe for and purchase (i) a portion of the total number of shares of Class B common stock,
par value $0.0001 per share, of the Company (“Class B Common Stock” and collectively with the shares of Class A Common
Stock, the “Common Stock”) at the closing of the Business Combination from the Sponsor (“Founder Shares”)
and (ii) Private Placement Warrants (together with the Founder Shares, the “Subscribed Securities”) at the IPO
Closing from the Company. For the avoidance of doubt, unless notified to the contrary prior to the Business Combination Closing, Valence
Investments shall be the purchaser of the Founder Shares and Valence Portfolios shall be the purchaser of the Private Placement Warrants
and the Public Shares.; and


 






     


     


    

 


WHEREAS, the Company and the Sponsor intend for
the purchase of Founder Shares and Private Placement Warrants as set forth herein to be made pursuant to Section 4(a)(1) and Section 4(a)(2)
of the Securities Act of 1933, as amended (the “Securities Act”), respectively.


  


NOW, THEREFORE, in consideration of the premises,
representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt,
sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:


 


1. Sale
and Purchase.


 


(a) Securities.


 


(i) Subject
to the terms and conditions hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company
agrees to issue and sell to the Purchaser, the number of Private Placement Warrants equal to seven and a half percent (7.50%) of the Private
Placement Warrants to be sold by the Company in connection with the IPO, at a purchase price of $1.50 per warrant (the “Initial
Purchase Price”).


 


(ii) On
the Business Combination Closing (as defined below), the Purchaser shall purchase from the Sponsor, and the Sponsor shall transfer and
sell to the Purchaser, the greater of: (A) 25% of the Initial Subscriber Founder Shares (the “Minimum Share Amount”) and (B)
the Initial Subscriber Founder Shares, less such number of shares subject to any Ownership Reduction (as defined below) and any Change
in Investment Reduction (as defined below). For purposes of this Agreement, the number of “Initial Subscriber Founder Shares”
shall be equal to five and a half percent (5.50%) of all of the Founder Shares issued and outstanding upon consummation of the IPO, subject
to adjustment as described herein. The purchase price for the Initial Subscriber Founder Shares shall be $0.006 per share, and shall be
paid by wire transfer of immediately available funds or other means approved by the Sponsor. If the Business Combination Closing has not
occurred by the date that is 24 months from the IPO Closing or any stockholder-approved extension period, then no such purchases shall
occur pursuant to this Section 1(a)(ii).


 


(iii) The
Purchaser acknowledges that the Subscribed Securities, and any securities of the Company that may be distributed to the Purchaser on account
of the Subscribed Securities (collectively, the “Securities”), will be subject to restrictions on transfer as set forth
in this Agreement.


 


(iv) The
Company shall notify the Purchaser in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective
Date”) at least three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit the
balance of the Initial Purchase Price for the Private Placement Warrants to the Company’s transfer agent (to be held in escrow pending
the IPO Closing), by wire transfer of immediately available funds or other means approved by the Company, on the date that is one (1)
Business Day prior to the Effective Date, or such other date as the Company and the Purchaser may agree upon in writing; provided,
however, that if the actual number of Public Units offered and sold in the IPO is less than 15,000,000 or greater than 60,000,000,
then the Purchaser shall not be obligated to remit the Initial Purchase Price as set forth in Section 1(a)(i) and any of the Purchaser,
the Company or the Sponsor may in its sole discretion terminate this Agreement which shall be of no further force or effect. As used herein,
“Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which
banking institutions are generally authorized or required by law or regulation to close in the City of New York, New York. If the IPO
Closing has not occurred by the date that is seven (7) Business Days after the date on which the Purchaser remitted the balance of
its Initial Purchase Price to the Company’s transfer agent, then, unless the Purchaser otherwise agrees in writing, the Company
will promptly cause its transfer agent to return such amounts to the Purchaser. If the IPO Closing has not occurred by September 30, 2021,
this Agreement shall terminate and be of no further force or effect.


 






    2


     


    

 


(v) In
the event that the underwriters’ over-allotment option in connection with the IPO (the “Over-allotment Option”)
is exercised, the Purchaser agrees to purchase an additional number of Private Placement Warrants equal to seven and a half percent (7.50%)
of the Private Placement Warrants to be sold by the Company in connection with the Over-allotment Option at a price of $1.50 per warrant.
The Company shall notify the Purchaser in writing of the anticipated date of each closing of the exercise of the Over-allotment Option,
if any (each, an “Over-allotment Closing”) at least three (3) Business Days prior to such Over-allotment Closing, and
the Purchaser shall pay the purchase price for the Private Placement Warrants to be purchased in connection with such Over-allotment Closing
by wire transfer of immediately available funds or other means approved by the Company on that date that is one (1) Business Day prior
to such Over-allotment Closing (to be held in escrow pending such Over-allotment Closing), or such other date as the Company and the Purchaser
may agree upon in writing. If the Over-allotment Closing has not occurred by the date that is seven (7) Business Days after the date
on which the Purchaser remitted the purchase price for the Private Placement Warrants to be purchased in connection with such Over-allotment
Closing, then, unless the Purchaser otherwise agrees in writing, the Company will promptly cause its transfer agent to return such amounts
to the Purchaser.


 


(vi) On
the date of the IPO Closing, the Company shall issue to the Purchaser the number of Private Placement Warrants that it has purchased pursuant
to Section 1(a)(i). On the date of each Over-allotment Closing, if any, the Company shall issue to Purchaser the number of Private Placement
Warrants that it has purchased pursuant to Section 1(a)(v). On each of the IPO Closing, an Over-allotment Closing and the Business Combination
Closing, the Purchaser shall deliver to the Company a schedule setting forth the number of Founder Shares and Private Placement Warrants,
as applicable, to be purchased by the Purchaser at such closing.


 


(b) Closing
Conditions. The Purchaser’s obligation to purchase the Subscribed Securities and the Sponsor’s and the Company’s
obligation to sell the Subscribed Securities to the Purchaser is conditioned upon satisfaction of the following conditions precedent (any
or all of which may be waived by the Company, the Sponsor and the Purchaser in its sole discretion with respect to the other parties’
conditions):


 


		(i)	On the IPO Closing or the Business Combination Closing, as applicable, no legal, administrative or regulatory action, suit or proceeding
shall be pending which seeks to restrain or prohibit the transactions contemplated by this Agreement; and



 


		(ii)	The representations and warranties of the Company, the Sponsor and the Purchaser, contained in this Agreement shall have been true
and correct on the date of this Agreement and shall be true and correct on the IPO Closing or the Business Combination Closing, as applicable,
as if made on the date of such closing (other than the representations and warranties set forth in Sections 4(b) and 4(h), which shall
be true and correct as of the IPO Closing).



 


 


(c) Delivery
of Securities.


 


(i) The
Company shall register the Purchaser as the owner of the Private Placement Warrants with the Company’s transfer agent by book entry
on or prior to the date of the IPO Closing (provided that prior to the Company’s appointment of a transfer agent it shall register
the Purchaser as the owner of such securities in the Company’s stock ledger upon issuance thereof).


 


(ii) Each
register and book entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall be
stamped or otherwise imprinted with a legend (in addition to any other required legends, as applicable), in substantially the following
form:


 


“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT
BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.


 


THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES
REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES
THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”


 






    3


     


    

 


(d) Legend
Removal. Following the expiration of the transfer restrictions set forth in Section 6(a), if the Securities are eligible
to be sold without restriction under Rule 144 under the Securities Act of 1933, as amended (the “Securities Act”),
or if they are registered for resale under the Securities Act pursuant to a shelf registration statement, then the Company will use its
best efforts to cause the Company’s transfer agent to remove the legend set forth in Section 1(c)(ii), subject to compliance
by the Purchaser with the reasonable and customary procedures for such removal required by the Company or its transfer agent. In connection
therewith, if required by the Company’s transfer agent, the Company will promptly cause an opinion of counsel to be delivered to
and maintained with its transfer agent, together with any other authorizations, certificates and directions required by the transfer agent
that authorize and direct the transfer agent to issue such Securities without any such legend.


 


(e) Registration
Rights. On the Effective Date, the Company shall enter into a Registration Rights Agreement (the “Registration Rights Agreement”)
with the Sponsor and certain other parties thereto, in substantially the form provided to the Purchaser prior to the date hereof.


 


2. Potential
Forfeiture. 


 


(a) If the
Purchaser does not purchase at least 9.9% of the Public Shares sold by the Company in the IPO, then the Purchaser shall automatically
forfeit its right to purchase any of the Initial Subscriber Founder Shares and shall forfeit all right, title or interest in, the Initial
Subscriber Founder Shares;


 


(b) If either
(A) the sum of (x) the Public Shares the Purchaser beneficially owns or holds, directly or indirectly, and (y) the number of shares of
Class A Common Stock for which the Purchaser has executed a binding commitment to purchase in connection with the closing of the Business
Combination at a price equal to or greater than $10.00 per share (or, for the avoidance of doubt, equivalent securities of the target
of the Business Combination or the successor registrant of the Company, in each case at price equivalent to at least $10.00 per share
of Class A Common Stock) (such sum, the “Total Closing Investment Shares”) does not equal or exceed the number of shares
that is 4.9% of the Public Shares (the “Forfeiture Threshold”) as of the date of the vote by the Company’s stockholders
to approve the Business Combination or the Business Day immediately prior to the closing of the Business Combination or (B) the Purchaser
redeems all or a portion of its Public Shares in connection with the Business Combination that results in the Total Closing Investment
Shares being less than the Forfeiture Threshold, then the number of Initial Subscriber Founder Shares that the Purchaser may purchase
pursuant to Section 1(a)(ii) shall be reduced pro rata by a fraction, the numerator of which shall equal the Forfeiture Threshold
less the Total Closing Investment Shares after giving effect to any redemptions of the Public Shares by the Purchaser and the denominator
shall equal the Forfeiture Threshold (the “Ownership Reduction”). By way of example and without limiting the foregoing,
in the event the Total Closing Investment Shares equals two and a half percent (2.5%) of the Public Shares (after giving effect to any
redemptions of the Purchaser’s Public Shares), the Purchaser shall forfeit 50% of its Initial Subscriber Founder Shares, in which
case the Ownership Reduction shall equal 50% of the Initial Subscriber Founder Shares. For the avoidance of doubt, no Ownership Reduction
shall result in the Purchaser having to forfeit or transfer any Private Placement Warrants.


 


(c) The
Purchaser agrees that if, prior to a Business Combination, the Sponsor’s managing members deem it necessary in order to facilitate
a Business Combination by the Company for the Sponsor to forfeit, transfer, exchange or amend the terms of all or any portion of the Founder
Shares and/or the Private Placement Warrants or to enter into any other arrangements with respect to the Founder Shares and/or the Private
Placement Warrants (including, without limitation, a transfer of the Sponsor’s membership interests representing an interest in
any of the foregoing) to facilitate the consummation of such Business Combination (each, a “Change in Investment”),
such Change in Investment shall apply pro rata to Purchaser (the “Change in Investment Reduction”) and the Sponsor
based on the relative number of Founder Shares and/or Private Placement Warrants held by each. By way of example and without limiting
the foregoing, in the event 50% of the Sponsor’s Founder Shares and/or Private Placement Warrants are forfeited or transferred by
the Sponsor as part of such Business Combination, the Purchaser shall forfeit or transfer 50% of its Initial Subscriber Founder Shares
and/or Private Placement Warrants on substantially the same terms and conditions as the Sponsor, in which case the Change in Investment
Reduction shall equal 50% of the Initial Subscriber Founder Shares.


 






    4


     


    

 


(d) Solely
by way of example to illustrate the provisions of Section 2, in the event the Sponsor forfeited or transferred 50% of
its Initial Subscriber Founder Shares and Private Placement Warrants to facilitate the consummation of a Business Combination, the Ownership
Reduction is 50% and the Change in Investment Reduction is 50%, then the percentage of the Initial Subscriber Founder Shares to be purchased
by the Purchaser shall be reduced 100% to zero; provided, however, that the Purchaser shall still have the right to purchase the Minimum
Share Amount. In addition, the Purchaser shall forfeit or transfer 50% of its Private Placement Warrants.


 


3. Representations
and Warranties of the Purchaser.  The Purchaser represents and warrants to the Company as follows, as of the date hereof:


 


(a) Organization
and Power.  The Purchaser is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its
formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.


 


(b) Authorization. 
The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser,
will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms,
except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws
of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.


 


(c) Governmental
Consents and Filings.  No consent, approval, order or authorization of, or registration, qualification, designation, declaration
or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the
consummation of the transactions contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or
regulations.


 


(d) Compliance
with Other Instruments.  The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the
Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i) under any provisions
of its organizational documents, (ii) under any instrument, judgment, order, writ or decree to which it is a party or by which it
is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease,
agreement, contract or purchase order to which it is a party or by which it is bound or (v) under any provision of federal or state
statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse
effect on the Purchaser’s ability to consummate the transactions contemplated by this Agreement.


 


(e) Purchase
Entirely for Own Account.  This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to
the Company, which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired
by the Purchaser will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view
to the resale or distribution of any part thereof in violation of any state or federal securities laws, and that the Purchaser has no
present intention of selling, granting any participation in, or otherwise distributing the same in violation of law. By executing this
Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement
with any Person (other than the Company) to sell, transfer or grant participations to such Person or to any third Person, with respect
to any of the Securities. For purposes of this Agreement, “Person” means an individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or any government or any department
or agency thereof.


 


(f) Disclosure
of Information.  The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs
and the terms and conditions of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s
management.


 






    5


     


    

 


(g) Restricted
Securities.  The Purchaser understands that the offer and sale of the Securities to the Purchaser has not been and will not be
registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends
upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed
herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state
securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered with
the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser
acknowledges that the Company has no obligation to register or qualify the Securities except pursuant to the Registration Rights Agreement. 
The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various
requirements including, but not limited to, the time and manner of sale, the holding period for the Securities, and on requirements
relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation and may not be
able to satisfy. The Purchaser acknowledges that the Company has confidentially submitted the Registration Statement for its proposed
IPO. The Purchaser understands that the offering of Securities and transactions contemplated hereunder are not and are not intended to
be part of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities Act with respect
to its purchase of Securities hereunder.


 


(h) No
Public Market.  The Purchaser understands that no public market now exists for the Securities, and that the Company has not made
any assurances that a public market will ever exist for the Securities.


 


(i) High
Degree of Risk.  The Purchaser understands that the purchase of the Private Placement Warrants involves a high degree of risk
which could cause the Purchaser to lose all or part of its investment.


 


 (j) Accredited
Investor.  The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the
Securities Act.


 


(k) No
General Solicitation.  Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners
has either directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general solicitation,
or (ii) published any advertisement in connection with the offer and sale of the Securities.


 


(m)    Adequacy
of Financing. The Purchaser will, when such funds are due hereunder, have sufficient funds to satisfy its obligations under this
Agreement.


 


(o) No
Other Representations and Warranties; Non-Reliance.  Except for the specific representations and warranties contained in this Section 3 and
in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor
any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser Parties disclaim any
such representation or warranty. Except for the specific representations and warranties expressly made by the Company in Section 4
of this Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim that they
are relying upon any other representations or warranties that may have been made by the Company, any person on behalf of the Company or
any of the Company’s affiliates (collectively, the “Company Parties”) with respect to the transactions contemplated
hereby.


 


4. Representations,
Warranties and Covenants of the Company. The Company represents, warrants and covenants to the Purchaser as follows:


 


(a) Organization
and Corporate Power.  The Company is incorporated and validly existing and in good standing as a corporation under the laws of
Delaware and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted.


 






    6


     


    

 


(b) Capitalization.
The authorized share capital of the Company consists, as of the date hereof:


 


(i)
200,000,000 shares of Class A Common Stock, none of which is issued and outstanding.


 


(ii) 20,000,000
shares of Class B Common Stock, 5,750,000 of which are issued and outstanding and held by the Sponsor and the other initial stockholders
of the Company. All of the outstanding shares of Class B Common Stock have been duly authorized, are fully paid and nonassessable and
were issued in compliance with all applicable federal and state securities laws.


 


(iii) 1,000,000
shares of preferred stock, none of which is issued and outstanding.


 


(c) Authorization.
All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company
to enter into this Agreement, and to issue the Private Placement Warrants, has been taken on or prior to the date hereof. All action on
the part of the stockholders, directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance
of all obligations of the Company under this Agreement, and the issuance and delivery of the Private Placement Warrants has been taken
on or prior to the date hereof. This Agreement, when executed and delivered by the Company, shall constitute the valid and legally binding
obligation of the Company, enforceable against the Company in accordance with its terms except (i) as limited by applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance, or other laws of general application relating to or affecting the enforcement
of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance, injunctive
relief, or other equitable remedies.


 


(d) Valid
Issuance of Private Placement Warrants.


 


(i) The
Private Placement Warrants, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement,
will be validly issued and fully paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges
with respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement, applicable
state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations
of the Purchaser in this Agreement and subject to the filings described in Section 4(e) below, the Private
Placement Warrants will be issued in compliance with all applicable federal and state securities laws, rules and regulations.


 


(ii) No
“bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except
for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
Person listed in the first paragraph of Rule 506(d)(1).


 


(e) IPO.


 


(i) The
Company has provided to the Purchaser, and will at all times prior to the consummation of the IPO promptly provide to the Purchaser, copies
of all correspondence sent by the Company to, or received by the Company from, the SEC.


 


(ii) The
offers and sales of securities in the IPO will be made pursuant to an effective Registration Statement and otherwise in compliance with
the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws, rules and regulations.


 


(f) Governmental
Consents and Filings.  Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental
authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.


 






    7


     


    

 


(g) Compliance
with Other Instruments.  The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in any violation or default (i) under any provisions of the certificate of incorporation, bylaws
or other governing documents of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company is a
party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound,
(iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) under
any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which
would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.


 


(h) Operations.
As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations other
than organizational activities and activities in connection with offerings of the Securities.


 


(i) Foreign
Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company
has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the
U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.


 


(j)  Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations,
including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of
2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.


 


(k)  Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of
the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.


 


(l) No
General Solicitation.  Neither the Company, nor any of its officers, managers, employees, agents or members has either directly
or indirectly, including, through a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement
in connection with the offer and sale of the Private Placement Warrants.


 


(m)    Non-Public
Information. The Company represents and warrants that none of the information conveyed to the Purchaser in connection with the transactions
contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness of the Registration
Statement.


 


(n) No
Other Representations and Warranties; Non-Reliance.  Except for the specific representations and warranties contained in this Section 4 and
in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any
other express or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties
specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties.


 






    8


     


    

 


5.
 Representations,
Warranties and Covenants of the Sponsor. The Sponsor represents, warrants and covenants as follows:


 


(a) Organization
and Power. The Sponsor is duly organized, validly existing, and in good standing under the laws of its jurisdiction of its formation
and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.


 


(b) Authorization.
The Sponsor has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Sponsor, will
constitute the valid and legally binding obligation of the Sponsor, enforceable against the Sponsor in accordance with its terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general application
affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies.


 


(c) Encumbrances.
The Initial Subscriber Founder Shares to be sold to the Purchaser (i) are owned by the Sponsor free and clear of any security interests,
liens, claims or other encumbrances, subject only to restrictions upon transfer under the Securities Act and any applicable state securities
laws and as described in the Registration Statement, (ii) are subject to certain transfer restrictions as set forth in the Registration
Statement, and (iii) will not subject the Purchaser to personal liability upon its acquisition of such Initial Subscriber Founder Shares
by reason of being a holder of such Initial Subscriber Founder Shares.


 


(d) No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section
5 and in any certificate or agreement delivered pursuant hereto, none of the Sponsor Parties has made, makes or shall be deemed to make
any other express or implied representation or warranty with respect to the Sponsor or the offering of Securities hereunder, and the Sponsor
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Sponsor Parties specifically disclaim
that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties.


 


6. Additional
Agreements and Acknowledgements of the Purchaser.


 


(a) Transfer
Restrictions.  The Purchaser agrees that it shall not Transfer (as defined below) (i) any Founder Shares (or any shares of Common
Stock issuable upon conversion of the Founder Shares) until the earlier of (A) one year after the closing of the Business Combination
(the “Business Combination Closing”) and (B) the date following the Business Combination Closing on which the
Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the
Company’s stockholders having the right to exchange their Common Stock for cash, securities or other property (such period, the
“Lock-up Period”) or (ii) any Private Placement Warrants (or any shares of Common Stock issuable upon exercise of the
Private Placement Warrants) until 30 days after the Business Combination Closing. Notwithstanding the foregoing, if subsequent to a Business
Combination, the closing price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share dividends,
reorganizations, recapitalizations and the like) for any twenty (20) trading days within any thirty (30) trading day period commencing
at least one hundred and fifty (150) days after the Business Combination Closing, the Founder Shares shall be released from the lockup
referenced in this Section 6(a). Notwithstanding the first sentence hereinabove, Transfers of the Securities are permitted (i) to
any other person or entity that holds Common Stock prior to the consummation of the IPO; (ii) to the Company’s officers, directors
or employees; (iii) in the case of an entity, as a distribution to its partners, stockholders or members upon liquidation; (iv) in
the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which is a member
of the individual’s immediate family, or an affiliate or such person, or to a charitable organization; (v) in the case of an
individual, by virtue of laws of descent and distribution upon death of the individual; (vi) in the case of an individual, pursuant
to a qualified domestic relations order; (vii) by pledges to secure obligations incurred in connection with purchases of the Company’s
securities; (viii) by private sales or transfers made in connection with the consummation of a Business Combination at prices no
greater than the price at which the applicable Securities were originally purchased; (ix) in the event of the Company’s liquidation,
bankruptcy or dissolution prior to the completion of a Business Combination; (x) to the Purchaser’s affiliates, to any investment
fund or other entity controlled or managed by the Purchaser, or to any investment manager or investment advisor of the Purchaser or an
affiliate of any such investment manager or investment advisor or to any investment fund or other entity controlled or managed by such
persons; (xi) to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses
(i) through (x) above; and (xii) pursuant to the provisions of Section 2 of this Agreement (each of the foregoing,
a “Permitted Transferee”); provided, however, that in the case of clauses (i) through (xi), these permitted transferees
must enter into a written agreement agreeing to be bound by the terms of this Agreement, including the forfeiture provisions of Section 2
and these transfer restrictions. As used in this Agreement, “Transfer” shall mean the (x) sale or assignment of,
offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement
to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease
of a call equivalent position (within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), and the rules and regulations of the SEC promulgated thereunder) with respect to, any of the Securities; (y) entry
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any
of the Securities, whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or (z) public
announcement of any intention to effect any transaction specified in clause (x) or (y); provided further, that this Section 6(a)
shall not prohibit the Purchaser from effecting a Short Sale (as defined below) with securities that do not constitute “Securities”
under this Agreement.


 






    9


     


    

 


(b) Trust
Account.


 


(i)  The
Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account for the benefit of its public stockholders
upon the IPO Closing. The Purchaser hereby agrees that it has no right, title, interest or claim of any kind in or to any monies held
in the Trust Account, or any other asset of the Company as a result of any liquidation of the Company, except for redemption and liquidation
rights, if any, the Purchaser may have in respect of any Public Shares held by it.


 


(ii) The
Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”)
to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it
may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares
held by it. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser shall pursue such Claim solely
against the Company and its assets outside the Trust Account and not against the property or any monies in the Trust Account, except for
redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it.


 


(c) No
Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf, will engage in any Short
Sales with respect to securities of the Company prior to the closing of the Business Combination. For purposes of this Section 6(c), “Short
Sales” shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO
under the Exchange Act, and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part
of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return
basis).


 


(d)
Use of Purchaser’s Name. Neither the Company nor the Sponsor will, without the written consent of the Purchaser in each instance,
use in advertising, publicity or otherwise the name of the Purchaser or any of its affiliates, or any director, officer or employee of
the Purchaser, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof
owned by the Purchaser or its affiliates or any information relating to the business or operations of the Purchaser or its affiliates
(including, for the avoidance of doubt, any investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the
Company may disclose (i) Purchaser’s name and information concerning the Purchaser (A) to the extent required by law,
regulation or regulatory request, including in the Registration Statement or (B) to the Company’s lawyers, independent accountants
and to other advisors and service providers who reasonably require Purchaser’s information in connection with the provision of services
to the Company, are advised of the confidential nature of such information and are obligated to keep such information confidential, and
(ii) Purchaser’s name and the terms of this Agreement to the other Subscription Parties. The Company and the Sponsor agree
to provide to the Purchaser for Purchaser’s review any disclosure in any registration statement, proxy statement or other document
in advance of the submission, filing or disclosure of such document in connection with the transactions contemplated by this Agreement
with respect to the Purchaser or any of its affiliates, and will not make any such submission, filing or disclosure without including
any revisions reasonably requested in writing by the Purchaser or to the extent the Purchaser has a good faith objection to such submission,
filing or disclosure.

 


(e) Stock
Exchange Listing. The Company will use commercially reasonable efforts to effect and maintain the listing of the Class A Common Stock
and Warrants on The Nasdaq Capital Market (or another national securities exchange) until the third anniversary of the Business Combination
Closing.


 






    10


     


    

 


7. General
Provisions.


 


(a) Notices. 
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic
mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s
next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid,
specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to:
Hennessy Capital Investment Corp. VI, 3415 N. Pines Way, Suite 204, Wilson, WY 83014, Attention: Daniel J. Hennessy, Email: dhennessy@hennessycapllc.com,
Gregory D. Ethridge, Email: gethridge@hennessycapllc.com and Nicholas A. Petruska, Email: npetruska@hennessycapllc.com, with a copy to
Sidley Austin LLP, One South Dearborn, Chicago, IL 60603, Attention: Michael P. Heinz, Email: mheinz@sidley.com and Dirk W. Andringa,
Email: dandringa@sidley.com.


 


  All
communications to the Purchaser shall be sent to the Purchaser’s mailing address or email address as set forth on the signature
page hereto, or to such email address, facsimile number (if any) or address as subsequently modified by written notice given in accordance
with this Section 7(a).


 


(b) No
Finder’s Fees.  Each party represents that it neither is nor will be obligated for any finder’s fee or commission
in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission
or compensation in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of
defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives are
responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in
the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against
such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.


 


(c) Survival
of Representations and Warranties.  All of the representations and warranties contained herein shall survive the consummation
of the transactions contemplated by this Agreement.


 


(d) Entire
Agreement.  This Agreement, together with any other documents, instruments and writings that are delivered pursuant hereto or
referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes
all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in
any way to the subject matter hereof or the transactions contemplated hereby.


  


(e) Successors. 
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to
the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.


 


(f) Assignments. 
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or
obligations hereunder without the prior written approval of the other party.


 






    11


     


    

 


(g) Counterparts. 
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute
one and the same instrument.


 


(h) Headings. 
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation
of this Agreement.


 


(i) Governing
Law.  This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether grounded
in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of
the State of New York, without giving effect to its choice of laws principles. 


 


(j)  Jurisdiction. 
The parties hereby irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United
States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or
based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement
except in state courts of New York or the United States District Court for the Southern District of New York, and (iii) waive, and
agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this
Agreement or the subject matter hereof may not be enforced in or by such court.


 


(k) WAIVER
OF JURY TRIAL.  THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS
AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.


 


(l)  Amendments. 
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of the Company
and the Purchaser.


 


(m) Severability. 
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party hereto
or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with its
terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have the power
to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases,
and in its reduced form, such provision will then be enforceable and will be enforced.


 


(n) Expenses. 
Each of the Company and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution and
performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents,
representatives, financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent,
stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable
upon conversion or exercise of the Securities.


 






    12


     


    

 


(o) Construction. 
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent
or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of
proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference
to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed
to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context
otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,” “hereunder,”
and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The
parties hereto intend that each representation, warranty, and covenant contained herein will have independent significance. If any party
hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation,
warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has
not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or
covenant.


 


(p) Waiver. 
No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not,
may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in
any way any rights arising because of any prior or subsequent occurrence.


 


(q) Specific
Performance.  Each party hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not
performed by the other party hereto in accordance with the terms hereof and that the such party shall be entitled to specific performance
of the terms hereof, in addition to any other remedy at law or equity.


 


(r)  Confidentiality. 
Except as may be required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the provisions
of Section 6(d) hereof), unless and until the transactions contemplated hereby and the terms hereof are publicly announced
or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the existence
or terms of this Agreement.  Notwithstanding the foregoing, the Purchaser shall be permitted to disclose any information to its affiliates
and its and their respective directors, officers, employees, advisors, director or indirect owners, agents and representatives, in each
case so long as such person or entity has been advised of the confidentiality obligations hereunder; provided that the Purchaser shall
be liable for any breach of such confidentiality obligations by any such person or entity.


 


[Signature page follows]


 




    13


     


    

IN WITNESS WHEREOF, the undersigned have
executed this Agreement to be effective as of the date first set forth above.


 


	 	

    COMPANY:

	 	 
	 	HENNESSY CAPITAL INVESTMENT CORP. VI 
	 	 
	 	By:	/s/ Daniel J. Hennessy
	 	Name:  	Daniel J. Hennessy
	 	Title: 	Chief Executive Officer
	 	
     

	 	SPONSOR:
	 	 
	 	HENNESSY CAPITAL PARTNERS VI LLC
	 	 
	 	By:	 /s/ Daniel J. Hennessy
	 	Name: 	Daniel J. Hennessy
	 	Title: 	Managing Member of Hennessy Capital Group, LLC, the managing
member of the Sponsor


 




    14


     


    

 


 


	 	PURCHASER:
	 	 
	 	D. E. SHAW VALENCE PORTFOLIOS, L.L.C.
	 	 
	 	By: 	/s/ Edwin Jager
	 	Name:  	Edwin Jager
	 	Title: 	Authorized Signatory 
	 	 
	 	D. E. SHAW VALENCE INVESTMENTS (CAYMAN) LIMITED
	 	
     

    

	 	By:	/s/ Edwin Jager
	 	Name: 	Edwin Jager
	 	Title: 	Authorized Signatory 



 


		Purchaser’s Address for Notices:
	 	 
	 	
    

    1166 Avenue of the Americas, 9th Fl

    New York, NY 10036




 




    15


     


    

 


Schedule 


 


	 	 	 	Number of
 Subscribed 

Securities	 	 	 	Initial Purchase

Price	 
	Initial Subscriber Founder Shares	 	 	[    ]	 	 	$	 [    ]	 
	Private Placement Warrants	 	 	[    ]	 	 	$	[    ]	 




 


Date of Closing:


 


At each of the IPO Closing, an Over-allotment
Closing and the Business Combination Closing, this schedule will be updated to reflect the number of Initial Founder Shares and Private
Placement Warrants to be purchased at such closing.


 


 


16